Status:
COMPLETED
Quality of Life in Patients With Multiple Myeloma
Lead Sponsor:
Ullevaal University Hospital
Conditions:
Multiple Myeloma
Quality of Life
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine Clinically important difference and Response shift in quality of life in patients with Multiple Myeloma.
Detailed Description
Multiple myeloma is a plasma cell tumor with an annual incidence of 6 pr. 100 000. In the absence of curative treatment, the aim of the therapy is not only to induce an objective response and a prolon...
Eligibility Criteria
Inclusion
- Multiple Myeloma
- Age \> 18 years
- Informed consent
Exclusion
- Terminal illness with life expectancy less than 3 months
- Unable to fill in a questionnaire in norwegian
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT00290095
Start Date
January 1 2006
End Date
June 1 2008
Last Update
March 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ullevaal University Hospital
Oslo, Norway, 0407